Category Archives: BioInformatics

[ACCESSWIRE] PITTSBURGH, PA / ACCESSWIRE / April 12, 2017 / Helomics Corporation (Helomics), a privately-held, healthcare company providing personalized medicine solutions for clients in the pharmaceutical, diagnostic, and biotech industries, today announced the launch of D-CHIP (Dynamic Clinical Health Insight Platform), a bioinformatics platform for use by pharmaceutical and diagnostic companies to power their precision medicine efforts. D-CHIP is a searchable, bioinformatics platform that can be used by researchers to mine proprietary data of rich multi-omic and clinical information on patients with cancer to drive biomarker discovery and development, virtual clinical trials, as well as patient recruitment and selection. Gerald J. Vardzel Jr., President and CEO of Helomics stated, "Pharmaceutical companies want access to multi-dimensional data on patients in order to get actionable insights. Medical centers and Hospital Integrated Delivery Networks possess large amounts of complex clinical data, but lack the bioinformatics and analytical platforms to fully leverage it. D-CHIP provides organization, and analytics for this clinical data to make it more useful to researchers." "D-CHIP is a secure, regulatory-compliant, cloud-based analytic portal," commented Robert Montgomery, Manager of IT and LIMS at Helomics. "This valuable platform will give research and development groups in pharmaceutical and diagnostic companies access to rich, … Continue reading →

The research report provides a thorough overview of the global Bioinformatics market, focusing on the vital growth prospects and promising opportunities. This report studies the rapid developments and growth Bioinformatics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, along with an analysis of leading companies and players. This press release was orginally distributed by SBWire Brooklyn, NY -- (SBWIRE) -- 04/06/2017 -- The research report provides a thorough overview of the global Bioinformatics market, focusing on the vital growth prospects and promising opportunities. The report offers an in-depth analysis, presenting information related to the latest trends, key drivers, technological advancements, recent developments, and several challenges in the global Bioinformatics market. In addition, the barriers and limitations faced by the prominent players operating in the global Bioinformatics market have been included in the scope of the research report in order to guide the readers in making appropriate and effective business decisions. This report studies Bioinformatics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global … Continue reading →

This Report studies key highlights, technological advancements in critical care equipments, government support and growing private sector investments in the healthcare industry, are key factors fuelling the growth of the critical care devices market in the emerging nations. This press release was orginally distributed by SBWire Albany, NY -- (SBWIRE) -- 04/10/2017 -- Market Research Hub (MRH) has recently published the latest market study to its online portal, which is titled as "Global Bioinformatics Partnering Terms and Agreements 2010 to 2017" This study offers professional analysis of the current state of Bioinformatics Partnering Terms and Agreements. Request Free Sample Report @ http://www.marketresearchhub.com/enquiry.php?type=S&repid=950345 The Global Bioinformatics Partnering Terms and Agreements 2010 to 2017 report provides comprehensive understanding and unprecedented access to the bioinformatics partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in bioinformatics partnering deals Deal terms analysis Partnering agreement structure Partnering contract documents Top deals by value Most active deal makers Financial deal terms for bioinformatics The Global Bioinformatics Partnering Terms and Agreements 2010 to 2017 report provides a comprehensive understanding and unprecedented access to the bioinformatics partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding … Continue reading →

(Credit: Alix Kreil/Shutterstock) When a sore throat and sinus congestion warrant a visit to the doctor, your physician will attempt to determine whether a cold virus or bacterial infection is to blameoftentimes without success. So, just to be safe, they might write a potentially unnecessary script for an antibiotic. But what if a nurse could swipe your saliva and run a quick genetic test for bacteria? If the test results are negative, you get a prescription for a decongestant and orders to get some rest, rather than contributing to the widespread overuse of antibiotics. Rapid genetic screening on a personal level can take the guesswork out of a doctor visit. But on a grander scale, quickly analyzing genetic data stands to revolutionize research into everything from the mutations causing various cancers to the Second You, your microbiome, or the bacteria living inside you.Genomics can also improve understanding of a range of diseases Alzheimers, irritable bowel syndrome, Crohns disease, for instance as well as how to grow algae to best produce oil to make gasoline. In medicine, genetic screening can tell hospital staff what pathogens inhabit the hospital environment. In environmental research, it can clarify how communities of microorganisms fix carbon … Continue reading →

global market for Bioinformatics is growing continuously and expected to reach USD ~13.5 Billion by the end of 2022,Bioinformatics Market by Application,by Technology and Services,by Sector This press release was orginally distributed by SBWire Pune, Maharashtra -- (SBWIRE) -- 04/07/2017 -- Market Highlights global market for Bioinformatics is growing continuously and expected to reach USD ~13.5 Billion by the end of 2022.The global Bioinformatics market has been evaluated as steadily growing market and it is expected that the market will continue to grow similarly in the near future. Generally, bioinformatics deals with information in the field of biology, information technology and computer science. Research is performed by biologists in laboratories which includes gene expression, DNA sequencing, protein sequences etc. Computer scientists are also involved in developing tools, software's and algorithms to store and analyze data. As of now, bioinformatics is used in various fields which includes biotechnology, waste cleanup, genome application, gene therapy etc. The global Bioinformatics market is driven by various factors, some of the major factors which help in increasing demand of bioinformatics are growing applications of bioinformatics in drug discovery and drug development and increasing bioinformatics support in development of medicines and clinical diagnostics. Rising need for … Continue reading →

Mumbai: Raymond McCauley is chair, Digital Biology at Singularity Universitya Silicon Valley think tank devoted to training leaders in exponential technologies. He is also part of the team that developed next generation DNA sequencing at Illumina, where he worked in bioinformatics, cancer sequencing, and personal genomics. In an email interview, McCauleywho is a speaker at the two-day SingularityU India Summit that begins on 7 Aprilspoke about the explosion in genomics research, gene editing tools like CRISPR-CAS9 and the consequences of bioinformatics and genetic testing on health and life insurance. Edited excerpts: The explosion in genomics research along with the widespread adoption of DNA sequencing is accelerating the growth of the genomics market across the globe. Have we reached an inflection point? As the price continues to drop for DNA sequencing, and all of the associated tools and services, we are seeing a larger market for those services really take off. The research market is strong, as always, and many new medical applications are driving new growth. And were actually seeing an explosion of consumer geneticspeople can use their genes to look at ancestry, optimize nutrition and athletic training, and even pick a good tasting wine. Gene sequencing and gene editing … Continue reading →

BANGALORE, India, April 3, 2017 /PRNewswire/ -- Strand Life Sciences today announced the release of version 3.0 of its flagship, next-generation sequencing (NGS) data analysis and visualization platform, Strand NGS. Benchmarked against the world's best, major enhancements in this release have led to significant improvements in accuracy, precision and speed of NGS data analysis at scientists' fingertips. This latest release adds considerable value to the Strand stack of artificial intelligence (AI)-powered bioinformatics and text mining platform, christened "Ramanujan" after two great intellectuals of Indian origin for their mathematical and linguistic prowess. Over a period of 15 years, Strand has honed and leveraged its proprietary AI platform, which it applies in NGS data analysis, clinical variant interpretation and reporting. The key highlight of this Strand NGS v3.0 release is a DNA-Seq workflow that is 1.5 to two times faster than the BWA-GATK best practices workflow including increased accuracy for variant calling with precision/recall rates as high as 99/ 98% on the entire call set and 97/ 92% on InDels, and powerful visualizations for each step that are not present in GATK. Other improvements include: "Anticipating the latest developments in genomics and healthcare, Strand has become a global leader in providing cutting-edge … Continue reading →

April 06, 2017 02:10 ET | Source: Curetis GmbH photo-release Curetis Starts Subsidiary Ares Genetics to Advance Genetic Antibiotic Resistance Testing - Successful completion of GEAR asset and know how transfer from Siemens to Curetis Amsterdam, the Netherlands, and Holzgerlingen, Germany, April 6, 2017 -- Curetis N.V. (the "Company" and, together with Curetis GmbH, "Curetis"), a developer of next-level molecular diagnostic solutions, today announced that the Company has established Ares Genetics GmbH, a wholly owned subsidiary of Curetis GmbH. Ares Genetics builds on GEAR GEnetic Antibiotic Resistance and Susceptibility Database and associated assets recently acquired for Siemens. The Company will use GEAR to investigate the genetic foundations of antibiotic resistance and develop and subsequently commercialize novel approaches to improve the rapid detection of antibiotic resistance in patients with microbial infections as well as tools to accelerate antibiotic research. Ares Genetics has been established in Vienna, Austria, in close proximity to the Vienna Biocenter VBC and is headed by Dr. Andreas Posch, who has joined Curetis in March from Siemens as Director GEAR & Bio-IT and one of the Managing Directors of Ares Genetics. Dr. Posch headed the bioinformatics activities at Siemens Healthcare and was responsible for GEAR prior to the … Continue reading →

Share The latest market report published by Credence Research, Inc.Global Bioinformatics Market Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 2023,thebioinformatics market was valued at USD 8,580.0 Mn in 2015, and is expected to reach USD 38,614.0 Mn by 2024, expanding at a CAGR of 20.3% from 2016 to 2024. Browse the fullreport Bioinformatics Market Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 2024 report at http://www.credenceresearch.com/report/bioinformatics-market Market Insights The key applications of bioinformatics comprises in gene sequence analysis, gene and protein expression analysis, gene regulation analysis, genome annotation, and mutation analysis. Bioinformatics plays key role in research optimization via effective data management during and after clinical trials. The factor assisting its market growth throughout the forecast period is existence of huge government funding and market introduction of technological advancements in the fields of genomics and proteomics. The market experts suggested that, market growth of bioinformatics has been also driven by the companies that express a need to adopt more cost-efficient and prolific methods to commercialize proprietary information. The suppliers operating in this market are expected to provide products or services such as complete integration of data infrastructure including data sharing facility, data security, data searching, proposed customization and data … Continue reading →

WASHINGTON, D.C.--(BUSINESS WIRE)--AACR 2017 Thermo Fisher Scientific, the world leader in serving science, will highlight its latest innovative solutions for research designed to help customers advance the future of precision medicine. The new products and a wide spectrum of scientific posters will be featured at the American Association for Cancer Research (AACR) 2017 Annual Meeting (booth #1727) at the Walter E. Washington Convention Center. Advancements in precision medicine are driving the need for innovative technologies designed to help our customers better understand the molecular makeup of disease so they may more effectively treat cancer in the future, said Joydeep Goswami, president of Clinical Next Generation Sequencing and Oncology for Thermo Fisher Scientific. Thermo Fisher is committed to enabling breakthroughs in the laboratory through its broad spectrum of solutions for the development of future clinical applications. New Featured Products at AACR Include: Ion Torrent Oncomine Knowledgebase Reporter via Thermo Fisher Connect, powered by Thermo Fisher Cloud, enables researchers to put sample-specific variants into context by linking them to labels, guidelines and global clinical trials. The tool also helps create a custom, lab-generated report in any of the 10 language templates built into the software. Updates to the data and improvements to … Continue reading →